We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Trust & Transparency
Medication pricing is famously opaque. Ours is not. Here is exactly how kindr Health pricing works, what we charge, what the pharmacy charges, what can change, when it can change, and what notice you will get if it does.
Last updated: May 15, 2026 · Reviewed quarterly
Every charge on your account is one of three things. Knowing which is which makes the rest of this page make sense.
| Line item | Who sets it | How stable is it? |
|---|---|---|
| Platform fee Clinician time, async messaging, support, software, compliance, lab review | kindr Health | Locked at signup. 30 days written notice required for any change. |
| Medication cost Pass-through from a state-licensed, FDA-registered pharmacy | Pharmacy | Usually stable, but can change with API supply, FDA enforcement, or wholesale shifts. |
| Optional add-ons Lab panels, expedited shipping, additional consults | kindr Health or third-party lab | Quoted at the time of order. You approve before charge. |
Here is the part the rest of the industry buries. Medication pricing in the United States — especially for compounded HRT and GLP-1s — sits on top of a supply chain that is genuinely unpredictable. We do not control most of it. What we control is whether we are honest about it.
Compounded medications are made from bulk active pharmaceutical ingredient (API) sourced from FDA-registered suppliers. API pricing fluctuates with global supply, import availability, and manufacturing capacity. When estradiol API rose 18% in 2024, every compounding pharmacy in the country saw it. When it fell again in early 2025, we passed those savings through. These changes typically happen no more than once or twice per year.
Section 503A of the Federal Food, Drug, and Cosmetic Act governs what compounding pharmacies are allowed to compound. The FDA maintains a drug shortage list. When a drug is on the shortage list, 503A pharmacies can compound the standard form. When the FDA declares the shortage resolved, 503A compounding of that drug must stop within 60 to 90 days. This is what happened with semaglutide (May 2025) and tirzepatide (October 2024).
When this happens, your clinician will discuss alternatives with you: a different formulation (oral vs. injectable), a different molecule (e.g. switching from semaglutide to tirzepatide, or to a branded product), or a dose change. Each alternative carries its own price. We will not switch your medication without your clinician discussing it with you first.
For brand-name medications (e.g. Wegovy, Zepbound, Mounjaro, Ozempic, branded estradiol patches), the price is set by the manufacturer. Manufacturers raise list prices roughly once a year, typically in January. We pass these increases through at cost.
Some medications (notably injectable GLP-1s) require refrigerated shipping. Carrier rate increases and fuel surcharges affect this line item. We absorb small fluctuations and only pass through changes greater than $5 per shipment.
How much warning you get before any price change, by category:
| Type of change | Minimum notice | How you are notified |
|---|---|---|
| Platform fee change | 30 days | Email + in-account banner |
| Plan structure change (new tiers, renaming) | 30 days | Email + in-account banner |
| Pharmacy wholesale increase passed through | 14 days when possible, minimum 7 days | |
| FDA-driven medication change (e.g. shortage resolved) | As soon as Kindr is notified, typically 30–60 days before required switch | Email + clinician message |
| Manufacturer list-price change (brand-name drugs) | 14 days | |
| Shipping cost change > $5/shipment | 14 days | |
| Price decrease | None — applied automatically | Reflected on next invoice |
We will not pretend medication pricing is more predictable than it is. Specifically:
What we can promise: when something changes, you hear it from us first, in plain language, before it hits your card.
Telehealth and direct-to-consumer pharmacy is a young industry. The standard playbook elsewhere is to bury price changes in fine print, auto-renew quietly, and make cancellation difficult. We think that approach is short-sighted and disrespectful of patients who are paying out of pocket for essential care.
Pricing is one of the most common reasons patients lose trust in a healthcare brand. Publishing this page is our way of saying: if our pricing ever changes, you should not have to read between the lines to figure out why. The answer should already be here.
It can, but it is uncommon. Your platform fee (the part Kindr keeps) is locked at the price you signed up for unless we give you advance written notice. The medication portion of your total is set by the pharmacy and can change if their wholesale costs change, if a formulation changes, or if FDA enforcement affects availability of compounded products.
For changes Kindr controls (platform fees, plan structure), we provide a minimum of 30 days written notice via email before your next billing cycle. For pharmacy-driven cost changes that we pass through, we notify you as soon as we are notified — which can range from 30 days to as little as 7 days depending on the supplier.
You can cancel anytime with 72 hours notice before your next billing cycle, no phone calls, no retention scripts. You can also switch to a different formulation, dose, or plan tier with your clinician. We will help you find the most affordable clinically appropriate option.
No. The medication line item on your invoice reflects what the pharmacy charges plus shipping. Kindr earns its revenue from the platform fee (clinician time, support, technology, compliance). We do not take a percentage of medication cost.
Compounded medications are prepared per-prescription by FDA-registered 503A pharmacies. Their pricing depends on bulk active pharmaceutical ingredient (API) availability, which fluctuates based on FDA shortage lists, import status, and global supply. Brand-name drugs are priced by the manufacturer and typically more stable but often significantly more expensive.
Section 503A of the FD&C Act governs compounding pharmacies. When the FDA removes a drug from its official shortage list, 503A pharmacies must stop compounding the standard version of that drug. This has happened with semaglutide and tirzepatide (GLP-1s). When this happens, your clinician may need to switch you to an alternative formulation, dose, or branded product — which may carry a different price.
Most Kindr plans are cash-pay and not billed to insurance. This keeps clinician time focused on you, not on prior authorizations. You can use HSA and FSA cards. Some lab work may be reimbursable through your insurance with a superbill on request.
Yes. When pharmacy costs decrease or we negotiate better rates, we pass savings through. We have done this previously when bulk estradiol pricing improved. Decreases are applied automatically to your next billing cycle.
Email support@kindr.health within 30 days of the charge. We will review your invoice line by line, explain every dollar, and refund any amount we cannot justify in writing.
Our current plans and prices are published at /plans. The page is dated and updated whenever pricing changes. Historical pricing is available on request.
If you see a charge you do not understand, or a price that does not match what you signed up for, email support@kindr.health with the subject line "Price discrepancy" and your order number. We respond within two business days with a line-by-line explanation, and refund any amount we cannot justify in writing.